TY - JOUR T1 - 6-Year Risk of Developing Lung Cancer in Spain: Analysis by Autonomous Communities JO - Archivos de Bronconeumología T2 - AU - Travier,Noemie AU - Fu,Marcela AU - Romaguera,Amparo AU - Martín-Cantera,Carlos AU - Fernández,Esteve AU - Vidal,Carmen AU - Garcia,Montse SN - 15792129 M3 - 10.1016/j.arbr.2020.03.033 DO - 10.1016/j.arbr.2020.03.033 UR - https://www.archbronconeumol.org/en-6-year-risk-developing-lung-cancer-articulo-S157921292100238X AB - IntroductionLung cancer screening with low-dose computed tomography (LDCT) has been proposed as a strategy to reduce lung cancer mortality. Since LDCT has side effects there is a need to carefully select the target population for screening programmes. Because in Spain health competences are transferred to the seventeen Autonomous Communities (ACs), the present paper aims to identify individuals at high risk of developing lung cancer in the different ACs. MethodsWe used the 2011–2012 data of the Spanish National Interview Health Survey (n=21,006) to estimate the proportion of individuals at high risk of developing lung cancer using a 6-year prediction model (PLCOm2012). This proportion was then extrapolated into absolute figures for the Spanish population, using the population census data of 2018 from the National Institute of Statistics. ResultsThe proportion of individuals aged 50–74 with a risk of lung cancer ≥2% was 9.5% (15.9% in men, 3.5% in women). This proportion ranged from 6.6% in Región de Murcia to 12.7% in Andalucía and 13.0% in Extremadura. When extrapolated to the Spanish population, it was estimated that a total of 1,341,483 individuals may have a 6-year risk of lung cancer ≥2%. ConclusionsThe present study is the first one that evaluated the number of individuals at high risk of developing lung cancer in the different Spanish ACs using a prediction model and selecting people with a 6-year risk ≥2%. Further studies should assess the cost and effectiveness associated to the implementation of a lung cancer screening programme to such population. ER -